Technology | Breast Imaging | January 25, 2017

HealthDecision LLC Launches Personalized Breast Cancer Screening Software Tool

Software embedded within electronic health records looks at patient’s healthcare data and history to calculate individual risk for developing breast cancer in the next decade

HealthDecision, Breast Cancer Screening tool, personalized risk, UW Health, launch

January 25, 2017 — HealthDecision LLC recently announced the launch of the Breast Cancer Screening tool. This tool provides patients a personalized risk analysis for developing breast cancer in the next 10 years and the benefits or harms associated with mammogram screening.

The tool was tested and currently is used within University of Wisconsin (UW) Health, a healthcare system in the upper Midwest serving 600,000 patients each year with 1,400 physicians and 16,500 staff at six hospitals and 80 outpatient sites.

The Breast Cancer Screening tool is the result of a 2013 WI Partnership Program grant received by the UW Madison Department of Radiology and a joint effort with HealthDecision LLC to create a shared decision-making (SDM) tool that could be used at a routine appointment within a doctor's office. The project grew out of the controversy and confusion about breast cancer screening, and its multidisciplinary team included members from surgery, engineering, psychology, communications, primary care, vascular surgery research and decision making.

HealthDecision is unique in that it is embedded within the electronic health record (EHR) system and considers the patient's healthcare data and history to calculate personalized risk. Risks associated with mammogram screening include over-detection and the subsequent effects of anxiety; possible overtreatment with surgery, radiotherapy and sometimes chemotherapy; cost; and additional impacts on quality of life.

"Healthcare guidelines can be confusing to patients as well as doctors, especially when there is conflicting information in the public domain," said Sarina Schrager, M.D., UW Health and professor in the University of Wisconsin Department of Family Medicine and Community Health. Along with Beth Burnside, M.D., UW Health, who was the principle investigator on the grant, Schrager was heavily involved in the development of the tool, educating other primary care clinicians and driving the implementation strategy within UW Health primary care. "HealthDecision aids my conversation with the patient to better educate and explain the harms and benefits of a mammogram and its possible outcomes. The visualized risk analysis has been key for patients to better understand their personalized risk and increases their confidence to make better informed healthcare decisions for themselves."

The Breast Cancer Screening tool joins a suite of three other HealthDecision shared decision-making tools that provide a patient's personalized risk for the various healthcare options available:

  • The Atrial Fibrillation tool demonstrates a patient's risk of stroke or bleeding from anticoagulant medications;
  • The Cardiovascular Risk tool evaluates a patient's cholesterol and their risk of various statin medications and smoking cessation; and
  • The Lung Cancer Screening tool considers the risk for chest computed tomography (CT) scans for patients who smoke or have smoked.

For more information: www.healthdecision.org

Related Content

News | Artificial Intelligence | May 11, 2021
May 11, 2021 — Whiterabbit, an AI technology company focused on early...
A 37-year-old woman developed a new, palpable left supraclavicular lymphadenopathy lump five days after her first dose of the Moderna COVID-19 vaccine in the left arm. On the day of vaccination, the patient was asymptomatic. This is an example of how the vaccine can mimic cancer and swollen lymph nodes. Image used with permission of RSNA.

A 37-year-old woman developed a new, palpable left supraclavicular lymphadenopathy lump five days after her first dose of the Moderna COVID-19 vaccine in the left arm. On the day of vaccination, the patient was asymptomatic. This is an example of how the vaccine can mimic cancer and swollen lymph nodes. Read more about this case study. Image used with permission of RSNA.

Feature | Coronavirus (COVID-19) | May 03, 2021 | By Dave Fornell, Editor
While the mass COVID-19 vaccinat
The Imagio Breast Imaging System combines laser light and sound with conventional ultrasound technology to provide fused functional and anatomic images (referred to as optoacoustic/ultrasound or OA/US) in real time, increasing confidence in diagnostic accuracy.

The Imagio Breast Imaging System combines laser light and sound with conventional ultrasound technology to provide fused functional and anatomic images (referred to as optoacoustic/ultrasound or OA/US) in real time, increasing confidence in diagnostic accuracy.

News | Breast Imaging | April 23, 2021
April 23, 2021 — The U.S.
A Norwegian study for the first time reveals benefit of the #PARP inhibitor #Olaparib in patients with early #breastcancer not harboring germline mutations

Getty Images

News | Radiation Therapy | April 22, 2021
April 22, 2021 — Targeted therapy in early stages of breas...